Essilorluxottica SA

ESLOF · NYSE

$182.20+$15.90 (+9.56%)TodayMarket closed ·
Prev close $166.30

About ESLOF

EssilorLuxottica SA engages in the design, manufacture, and distribution of ophthalmic lenses, frames and sunglasses. The company is headquartered in Paris, Ile-De-France and currently employs 203,791 full-time employees. Its operations include Ophthalmic Lenses & Optical Instruments, Eye wear such as Frames and Sunglasses, Retail and Distribution Networks, and Equipment Manufacturing. The company designs and produces corrective lenses incorporating technologies for addressing myopia, hypermetropia, and astigmatism. The company also manufactures and markets both prescription and non-prescription frames and sunglasses. In addition, EssilorLuxottica develops and supplies machines, tools, and consumables used by prescription laboratories and optical professionals. The firm further offers non-prescription reading glasses, fashion eye wear, and related consumer accessories, as well as selected apparel, footwear, and accessories through its associated brands.

Employees
203,791
Headquarters
Paris, Ile-De-France
Listed
Jan 1, 1975
Sector
Health Care
Industry
Health Care Equipment & Supplies

ESLOF key statistics

Market cap
71.49B
Price-earnings ratio
0.00
Dividend yield
2.33%
Average volume
6.80K
Volume
2.20K
Open price
$167.54
High today
$182.20
Low today
$167.54
52 Week high
$376.38
52 Week low
$156.36

Essilorluxottica SA (ESLOF) at a glance

Essilorluxottica SA (ESLOF) last traded at $182.20, with a market cap of 71.49B, a price-to-earnings ratio of 0.00 and a dividend yield of 2.33%.

Today the stock has traded between $167.54 and $182.20. The current price is 8.8% above the day's low and 0.0% below its high.

Volume so far is 2.20K shares, below the average of 6.80K shares a day.

Over the past year Essilorluxottica SA has ranged from $156.36 to $376.38, and now sits 12% of the way up that range.

Essilorluxottica SA met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $4.14 per share against an estimate of $3.90.

ESLOF earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 4.0% on average.

  1. Q4 FY22: reported $2.93 per share against an estimate of $2.78
  2. Q2 FY23: reported $3.68 per share against an estimate of $3.66
  3. Q4 FY23: reported $2.86 per share against an estimate of $2.95
  4. Q2 FY24: reported $3.81 per share against an estimate of $3.90
  5. Q4 FY24: reported $2.98 per share against an estimate of $3.05
  6. Q2 FY25: reported $3.89 per share against an estimate of $4.06
  7. Q4 FY25: reported $2.96 per share against an estimate of $3.01
  8. Q2 FY26: reported $4.14 per share against an estimate of $3.90

ESLOF news

  • Reported Earlier: Meta Announces Partneriship With EssilorLuxottica To Launch Meta Glasses

  • Ananya Gairola

    Meta Reportedly Plans To Expand Smart Glasses Push With New Prescription Ray-Ban Models, Targeting Billions Of Everyday Eyewear Users

  • 'Meta, EssilorLuxottica Sued in Smart Glasses Patent Case' - Bloomberg

  • Lekha Gupta

    Consumer Tech News (Oct 6-10): China Hits Nvidia, Tesla Tests Cybercab, Sunak Joins Microsoft & More

  • Anusuya Lahiri

    Meta, Ray-Ban Target 10 Million AI Glass Production By 2026

  • 'Ray-Ban Maker EssilorLuxottica Sales Top Estimates'- Bloomberg

  • Ananya Gairola

    Mark Zuckerberg-Led Meta Acquires Nearly 3% Of Ray-Ban, Oakley Parent EssilorLuxottica In $3.5 Billion Deal: Report

  • 'Meta Invests $3.5 Billion in EssilorLuxottica in AI Glasses Push' - Bloomberg News

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.